Skip to content
Clinical Trials – home
Verifiedinfo

Virgen del Rocío University Hospital

Spain Avenida De Manuel Siurot S/n, 41013 Sevilla, Spain

  • 300 trials recruiting
  • Non-small cell lung cancer · Acute myeloid leukaemia · Non-small cell lung cancer metastatic
  • Adults and children

About Specializations

Virgen del Rocío University Hospital in Sevilla, Spain specialises in clinical trials of conditions such as Non-small cell lung cancer, Acute myeloid leukaemia, Non-small cell lung cancer metastatic, Plasma cell myeloma, and other specialisations. This site conducts important research.

Main research areas of the site

Psychiatry and Psychology

At Virgen del Rocío University Hospital, the clinical trial portfolio is centered on Psychiatry and Psychology, with a strong focus on Mental Disorders. The research is primarily aimed at understanding and improving care for people living with schizophrenia, including studies that explore whether new approaches can support cognitive function and daily mental performance.

  • Key disease focus: schizophrenia
  • Main research goal: evaluating whether new therapies can improve cognitive impairment
  • Overall emphasis: advancing treatment options in mental health

This work reflects a clear commitment to better diagnostics and treatment effectiveness in severe psychiatric illness, supported by a large investigator network at the site.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Avenida De Manuel Siurot S/n41013 SevillaSpain
Recruiting now
300 trials
Conditions studied
225
Partner status
Verified

More sites in SevillaSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

1 012 clinical trials

Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Indacaterol Acetate
  • Sponsor:Novartis Pharma AG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Almirall S.A.
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:MOLNUPIRAVIR
  • Sponsor:Merck Sharp & Dohme LLC
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:NAVENIBART
  • Sponsor:Astria Therapeutics Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).